Medindia

X

Thomson Reuters and CareEvolution Collaborate to Empower Physicians to Improve Care Coordination

Thursday, August 7, 2008 General News J E 4
Advertisement
ANN ARBOR, Mich., Aug. 6 When doctors review a patient'smedical records, the information is presented chronologically and notorganized in a meaningful way.

Thomson Reuters and CareEvolution are working together to deliver analternative -- an application that groups patient data by disease or medicalepisode. This Web-based "medical episode grouper" provides current patientinformation -- logically organized, at the point of care -- to help physiciansmake sound medical decisions and enhance disease management and quality ofcare.

CareEvolution is a leading provider of secure interoperability solutionsthat link diverse technology platforms for medical records. Under thiscollaboration, output from the Medical Episode Grouper (MEG), developed byThomson Reuters, would be integrated into CareEvolution's clinical cockpit todeliver comprehensive patient medical histories of all medications andtreatments.

"Caregivers tell us they need access to a community-wide health historyfor a patient, but they are already overwhelmed with too much information.Dumping more data from more clinics and hospitals onto the doctor's desktop isnot going to be accepted or effective," said Vik Kheterpal, M.D., principal atCareEvolution.

"Organizing the discrete, fragmented, healthcare data we get from medicalclaims, acute and ambulatory electronic medical records and other sources intodisease-based clusters is critical to deal with this cognitive overload," hesaid. "Delivering patient information in this way enables clinicians to easilyfind the links between diseases and complications so they can better managethe patient's care."

Treatment of a given disease or medical complaint typically involvesseveral healthcare events -- such as a visit with a primary care doctor,prescriptions, visits to urgent care centers or the emergency room,consultations with specialists and perhaps admission to a hospital or surgerycenter.

CareEvolution uses a federated data model to pull patient data fromdifferent sources into a single unified view. Under this collaboration, itwould use the web-based MEG service to produce a clinically grouped view --streamlining information that represents a patient's lifetime of healthcareevents across pharmacy, laboratory, acute care, and ambulatory care settings.

"MEG enables physicians to quickly grasp the complexity and severity of apatient's condition," said Jon Newpol, executive vice president for theHealthcare business of Thomson Reuters. "Coupled with CareEvolution'ssoftware, this patient profile can provide physicians with a timely,easy-to-use summary of their patients' medical care."

About Thomson Reuters

The Healthcare business of Thomson Reuters produces insights, information,benchmarks and analysis that enable organizations to manage costs, improveperformance and enhance the quality of healthcare. Thomson Reuters is theworld's leading source of intelligent information for businesses andprofessionals. We combine industry expertise with innovative technology todeliver critical information to leading decision makers in the financial,legal, tax and accounting, scientific, healthcare and media markets, poweredby the world's most trusted news organization. With headquarters in New Yorkand major operations in London and Eagan, Minnesota, Thomson Reuters employsmore than 50,000 people in 93 countries. Thomson Reuters shares are listed onthe New York Stock Exchange (NYSE: TRI); Toronto Stock Exchange (TSX: TRI);London Stock Exchange (LSE: TRIL); and Nasdaq (Nasdaq: TRIN). For moreinformation, go to www.thomsonreuters.com .

About CareEvolution

CareEvolution is a leading provider of secure health interoperabilitysolutions. HIEBus(TM) (Health Information Exchange BUS) is a proven,comprehensive suite of SOA technology solutions for deploying healthinformation exchanges -- hospital to physici
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Eli Lilly and Company Showcases National Diabetes ...
S
Interleukin Genetics Announces Conference Call and...